WorldQuant Millennium Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,051
Closed -$2.71M 412
2022
Q3
$2.71M Buy
+11,051
New +$2.98M 0.07% 245
2019
Q4
Sell
-119,298
Closed -$21.2M 331
2019
Q3
$21.2M Sell
119,298
-11,146
-9% -$2.41M 0.41% 95
2019
Q2
$34M Buy
130,444
+107,141
+460% +$28.4M 0.65% 49
2019
Q1
$6.66M Buy
23,303
+14,915
+178% +$4.96M 0.16% 161
2018
Q4
$2.73M Buy
8,388
+6,527
+351% +$2.27M 0.08% 209
2018
Q3
$837K Buy
+1,861
New +$734K 0.03% 240

Other funds holding ABMD

WorldQuant Millennium Advisors's ABMD Position: Q4 2022 in Review

WorldQuant Millennium Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11,051 shares — an estimated $2.71M sold.

WorldQuant Millennium Advisors first reported a position in ABMD in Q3 2018 and held it in 6 quarters. The position peaked at $34M in Q2 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • WorldQuant Millennium Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 11,051 Abiomed Inc shares in Q4 2022, an estimated $2.71M.
  • WorldQuant Millennium Advisors first reported a position in Abiomed Inc in Q3 2018 and held it in 6 quarters.
  • WorldQuant Millennium Advisors's Abiomed Inc position peaked at $34M in Q2 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on WorldQuant Millennium Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.